Liver fat biomarkers study from the 'Personalized diet intervention to treat fatty liver' project
Rasvamaksan biomarkkeriaineisto hankkeesta Personoitu ravitsemusinterventio rasvamaksan hoitamiseksi
Anastasiia Driuchina; Jukka Hintikka; Marko Lehtonen; Pekka Keski-Rahkonen; Thomas O’Connell; Risto Juvonen; Juho Kuula; Antti Hakkarainen; Jari A. Laukkanen; Elina Mäkinen; Sanna Lensu et al. (2023). Liver fat biomarkers study from the 'Personalized diet intervention to treat fatty liver' project. 10.17011/jyx/dataset/85068
Tekijät
Muut tutkimuksen toteuttamiseen osallistuneet
Helsingin yliopisto; University of Jyväskylä; University of Eastern Finland; Hospital District of Helsinki and Uusimaa; University of Helsinki; Jyväskylän yliopisto; Itä-Suomen yliopisto (ISY); Helsingin ja Uudenmaan sairaanhoitopiiriPäivämäärä
2023Pääsyrajoitukset
Restricted use due to personal information protection. You can still contact author to ask for a copy of the material.
Tekijänoikeudet
Pekkala, Satu and University of Jyväskylä
The study aimed at finding gut microbiota signatures and metabolite markers in plasma and feces related to high liver fat content in humans. Based on imaging, we divided study participants into low (<5%, LF, n=25) and high (>5%, HF, n=39) liver fat groups. Fecal (LF n=14, HF n=25) and plasma (LF n=11, HF n=7) metabolomes of subsets of participants were studied using liquid chromatography/high resolution mass spectrometry. The gut microbiota were analyzed using 16S rRNA gene sequencing. Additionally, blood clinical variables, body composition and diet were studied.
The list of metadata variables can be found below. They are categorized by the type of sample and/or analysis.
BLOOD CLINICAL VARIABLES & UNITS
alanine aminotransferase, ALT (U/L)
aspartate aminotransferase, AST (U/L)
gamma-glutamyltransferase, GGT(U/L)
total cholesterol (mmol/L)
high-density lipoprotein, HDL (mmol/L)
low-density lipoprotein, LDL (mmol/L)
triglycrides (mmol/L)
glucose (mmol/L)
insulin (iU/L)
HOMA-IR
BODY COMPOSITION VARIABLES & UNITS
Height (cm)
Weight (kg)
body mass index, BMI (kg/m2)
Waist circumference (cm)
blood pressure (BP) systolic (mm Hg)
blood pressure (BP) diastolic (mm Hg)
Liver fat %
GUT MICROBIOTA COMPOSITION
fastq files of the sequences
OUT counts per each sample
relative abundance per each sample
diversity measures (Shannon, Chao1, phylogenetic diversity, Bray Curtis distance)
METABOLITES
plasma metabolites & identification information
fecal metabolites & identification information
DIETARY INTAKES & UNITS (from 3 different days & average from 3 days)
Energy (kJ)
Energy (kcal)
Protein (g)
Carbohydrates (g)
Fat (g)
Alcohol
Coffee (dl/3 days) *
Fatty acids (g)
Monosaturated Fatty acids (g)
Polyunsaturated Fatty acids (g)
Sucrose (g)
Fiber, total (g)
Vitamin C (mg)
Thiamine (B1) (mg)
Vitamin E (mg)
Vitamin A (µg)
Vitamin D (µg)
Riboflavin (B2) (mg)
Vitamin K (mg)
Vitamin B6 (mg)
Folate (B9) (µg)
Sodium (mg)
Magnesium (mg)
Calcium (mg)
Potassium (mg)
Iron (mg)
Iodine (µg)
Phosphorus (mg)
Selenium (µg)
Zinc (mg)
Fatty acids, total (g)
Cholesterol (mg)
Fatty acids, trans (g)
Lactose (g)
Fiber, total amount (g)
Vitamin B12 (cobalamine) (µg)
Salt (mg)
Omega-6 Fatty acids (g)
Omega-3 Fatty acids (g).
...
Asiasanat
Aineisto tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/ResearchDataset/172576021
Metadata
Näytä kaikki kuvailutiedotKokoelmat
- Tutkimusdata [277]
Rahoittaja(t)
Academy of Finland; Suomen AkatemiaRahoitusohjelmat(t)
Academy Research Fellow, AoF; Akatemiatutkija, SALisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
Driuchina, Anastasiia; Hintikka, Jukka; Lehtonen, Marko; Keski-Rahkonen, Pekka; O’Connell, Thomas; Juvonen, Risto; Kuula, Juho; Hakkarainen, Antti; Laukkanen, Jari A.; Mäkinen, Elina; Lensu, Sanna; Pietiläinen, Kirsi H.; Pekkala, Satu (American Society for Microbiology, 2023)Numerous studies have described specific metabolites as biomarkers ofsevere liver diseases, but very few have measured gut microbiota (GM)-produced metab-olites in fatty liver disease. We aimed atfinding GM signatures and ... -
The impact of maternal weight in pregnancy on glucose metabolism in non-diabetic offspring in late adulthood
Westberg, Anna P.; Kautiainen, Hannu; Salonen, Minna K.; Kajantie, Eero; von Bonsdorff, Mikaela; Eriksson, Johan G. (Elsevier, 2019)Aims We aimed to examine the association between maternal adiposity and glucose metabolism in adult offspring without diabetes, simultaneous taking offspring own adiposity into account. Methods This longitudinal birth ... -
The effects of physical activity and diet change on intracellular lipids and metabolism in mice with diet-induced obesity
Rinnankoski-Tuikka, Rita (University of Jyväskylä, 2014) -
Effects of a short-term resistance training protocol on risk factors for the metabolic syndrome in the elderly
Inglis, Alistair (2016)The metabolic syndrome is strongly associated with negative health outcomes, such as type 2 diabetes, cardiovascular disease and death. The elderly are at particularly high risk of developing the metabolic syndrome, owing ... -
The association of physical activity, insulin sensitivity, and dietary factors with hepatic steatosis : a cross-sectional analysis from DR’s EXTRA Study
Karppinen, Miira (2024)Ei-alkoholiperäinen rasvamaksa (engl. non-alcoholic fatty liver disease, NAFLD) on nykyisin yleisin maksasairaus länsimaissa. Fyysinen aktiivisuus ja Välimeren ruokavalio ovat NAFLD:ltä suojaavia tekijöitä, kun taas ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.